SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 191.09 |
Enterprise Value ($M) | 79.82 |
Book Value ($M) | 212.08 |
Book Value / Share | 5.03 |
Price / Book | 0.90 |
NCAV ($M) | 201.87 |
NCAV / Share | 4.79 |
Price / NCAV | 0.95 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.44 |
Return on Assets (ROA) | -0.26 |
Return on Equity (ROE) | -0.34 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.24 |
Current Ratio | 6.24 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 243.69 |
Assets | 253.90 |
Liabilities | 41.82 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 51.13 |
Operating Income | -116.22 |
Net Income | -93.80 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -127.16 |
Cash from Investing | 78.04 |
Cash from Financing | 0.84 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Blue Owl Capital Holdings LP | 7.41 | ||
13G/A | Deep Track Capital, LP | 7.10 | 9.72 | |
13G/A | Redmile Group, LLC | 5.10 | -19.95 | |
13G/A | ARK Investment Management LLC | 6.70 | 16.21 | |
13D/A | Biotechnology Value Fund L P | 24.50 | 13.57 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
7,898 | 111,706 | 7.07 | |
8,614 | 128,660 | 6.70 | |
8,147 | 57,887 | 14.07 | |
7,192 | 72,834 | 9.87 | |
(click for more detail) |
Similar Companies | |
---|---|
RLYB – Rallybio Corporation | ROIV – Roivant Sciences Ltd. |
RPRX – Royalty Pharma plc | RVMD – Revolution Medicines, Inc. |
RXRX – Recursion Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io